UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.167

Sortiert nach

Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor

Cell, 2018-11, Vol.175 (6), p.1665-1678.e18

2018

Volltextzugriff (PDF)

Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer

Cancer discovery, 2021-09, Vol.11 (9), p.2168-2185

2021

Volltextzugriff (PDF)

A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma

Nature cell biology, 2018-10, Vol.20 (10), p.1203

2018

Volltextzugriff (PDF)

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas

Nature communications, 2020-08, Vol.11 (1), p.1-10, Article 3883

2020

Volltextzugriff (PDF)

ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages

Nature communications, 2020-06, Vol.11 (1), p.2978-2978, Article 2978

2020

Volltextzugriff (PDF)

A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS Mutations

Clinical cancer research, 2020-10, Vol.26 (19), p.5113-5119

2020

Volltextzugriff (PDF)

Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma

Genome Biology, 2020-08, Vol.21 (1), p.216-17, Article 216

2020

Volltextzugriff (PDF)

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities

Nature communications, 2020-07, Vol.11 (1), p.3288-3288, Article 3288

2020

Volltextzugriff (PDF)

Differentiating loss of consciousness causes through artificial intelligence-enabled decoding of functional connectivity

NeuroImage (Orlando, Fla.), 2024-08, Vol.297, p.120749, Article 120749

2024

Volltextzugriff (PDF)

Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial

Genome medicine, 2022-01, Vol.14 (1), p.1-15, Article 1

2022

Volltextzugriff (PDF)

Genomic Landscape and Clinical Utility in Korean Advanced Pan-Cancer Patients from Prospective Clinical Sequencing: K-MASTER Program

Cancer discovery, 2022-04, Vol.12 (4), p.938-948

2022

Volltextzugriff (PDF)

Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma

Biomedicine & pharmacotherapy, 2023-12, Vol.168, p.115792-115792, Article 115792

2023

Volltextzugriff (PDF)

Integrative multi-omics characterization reveals sex differences in glioblastoma

Biology of sex differences, 2024-03, Vol.15 (1), p.23-23, Article 23

2024

Volltextzugriff (PDF)

Nutlin-3a induces KRAS mutant/p53 wild type lung cancer specific methuosis-like cell death that is dependent on GFPT2

Journal of experimental & clinical cancer research, 2023-12, Vol.42 (1), p.338-338, Article 338

2023

Volltextzugriff (PDF)

Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial

Genome medicine, 2021-01, Vol.13 (1), p.11-12, Article 11

2021

Volltextzugriff (PDF)

Calcipotriol, a synthetic Vitamin D analog, promotes antitumor immunity via CD4+T-dependent CTL/NK cell activation

Biomedicine & pharmacotherapy, 2022-10, Vol.154, p.113553-113553, Article 113553

2022

Volltextzugriff (PDF)

Large-Scale Cancer Genomic Analysis Reveals Significant Disparities between Microsatellite Instability and Tumor Mutational Burden

Cancer epidemiology, biomarkers & prevention, 2024-05, Vol.33 (5), p.712

2024

Volltextzugriff (PDF)

PIP4K2A as a negative regulator of PI3K in PTEN - deficient glioblastoma

The Journal of experimental medicine, 2019-05, Vol.216 (5), p.1120-1134

2019

Volltextzugriff (PDF)

Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain

International journal of molecular sciences, 2017-09, Vol.18 (9), p.1968

2017

Volltextzugriff (PDF)

Corrigendum to “Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer” [Gynecologic Oncology, Volume 165, Issue 2, May 2022, Pages 270–280]

Gynecologic oncology, 2022-08, Vol.166 (2), p.370-371

2022

Volltextzugriff (PDF)

Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma

Cell death & disease, 2021-04, Vol.12 (4), p.374-374, Article 374

2021

Volltextzugriff (PDF)

Ly6G + inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model

Cell death and differentiation, 2019-10, Vol.26 (10), p.2139-2156

2019

Volltextzugriff (PDF)

Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (18), p.4973-4984

2017

Volltextzugriff (PDF)

Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer

Gynecologic oncology, 2022-05, Vol.165 (2), p.270-280

2022

Volltextzugriff (PDF)

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers

Genome Biology, 2019-11, Vol.20 (1), p.253-253, Article 253

2019

Volltextzugriff (PDF)

1 – 25 von 1.167

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(872)
Mit Volltextzugriff
(1.061)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(492)
Life Sciences & Biomedicine
(401)
Humans
(245)
Animals
(141)
Biological And Medical Sciences
(124)
Female
(124)
Male
(119)
Physical Sciences
(85)
Medical Sciences
(82)
Biochemistry & Molecular Biology
(61)
Mice
(61)
Middle Aged
(56)
Oncology
(55)
Adult
(54)
Chemistry
(53)
Fundamental And Applied Biological Sciences. Psychology
(49)
Technology
(46)
Aged
(44)
Tumors
(38)
Mutation
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor

Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer

A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas

ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages

A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS Mutations

Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities

Differentiating loss of consciousness causes through artificial intelligence-enabled decoding of functional connectivity

Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial

Genomic Landscape and Clinical Utility in Korean Advanced Pan-Cancer Patients from Prospective Clinical Sequencing: K-MASTER Program

Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma

Integrative multi-omics characterization reveals sex differences in glioblastoma

Nutlin-3a induces KRAS mutant/p53 wild type lung cancer specific methuosis-like cell death that is dependent on GFPT2

Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial

Calcipotriol, a synthetic Vitamin D analog, promotes antitumor immunity via CD4+T-dependent CTL/NK cell activation

Large-Scale Cancer Genomic Analysis Reveals Significant Disparities between Microsatellite Instability and Tumor Mutational Burden

PIP4K2A as a negative regulator of PI3K in PTEN - deficient glioblastoma

Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain

Corrigendum to “Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer” [Gynecologic Oncology, Volume 165, Issue 2, May 2022, Pages 270–280]

Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma

Ly6G + inflammatory cells enable the conversion of cancer cells to cancer stem cells in an irradiated glioblastoma model

Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling

Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers

Suchergebnisse filtern